The US has approved the most expensive drug in the world worth 2.8 million dollars.
“Report” informs with reference to “Reuters” that the product named “Zinteglo” has been approved by the US Food and Drug Administration for gene therapy of one of the rare types of anemia.
There are about 1,500 thalassemia patients in the United States who will begin treatment with Zinteglo by the end of 2022. It is enough to completely eliminate the symptoms.
Its use involves removing bone marrow cells and introducing the “correct” version of the gene that causes thalassemia.
Treatment, as a rule, is not paid for by the patient himself, but by his insurance company or the state.